Midgard Science

EpiVax

Providence, RI, United States epivax.com

From their website, Nov 2026

Work here? Claim this listing

About

EpiVax provides immunogenicity assessment services for biologic and vaccine developers. It combines in silico analysis, in vitro assays, and consulting to support programs from early discovery through regulatory submission. The company is based in Providence, Rhode Island, USA.

Services

  • ISPRI™ Downselect™

    In silico service that helps identify candidates with the lowest immunogenic risk early in development.

    Assays & in vitro testing

  • ISPRI™ Quantify™

    In silico service for assessing overall and regional immunogenic and tolerogenic potential in therapeutic sequences.

    Assays & in vitro testing

  • ISPRI™ Analyze™

    In silico service for therapeutic immunogenicity analysis within the ISPRI toolkit.

    Assays & in vitro testing

  • ISPRI™ Evaluate™

    In silico service for therapeutic immunogenicity evaluation within the ISPRI toolkit.

    Assays & in vitro testing

  • ISPRI-HCP™

    In silico service focused on immunogenicity-related analysis within the ISPRI toolkit.

    Assays & in vitro testing

  • ISPRI™ Design™

    In silico service for optimizing protein regions and supporting peptide design for testing.

    Assays & in vitro testing

  • PANDA® Screening

    In silico screening service related to immunogenicity assessment.

    Assays & in vitro testing

  • iVAX™

    Web-based computational vaccine design toolkit for epitope mapping, antigen selection, immunogen design, and vaccine efficacy prediction.

    Assays & in vitro testing

  • EpiCC™

    Fee-for-service vaccine analysis offered as part of the vaccine in silico services.

    Assays & in vitro testing

  • PreVAX™

    Fee-for-service vaccine analysis offered as part of the vaccine in silico services.

    Assays & in vitro testing

  • All In Vitro Assays

    Experimental in vitro assays used to validate in silico predictions and assess immunogenicity factors.

    Assays & in vitro testing

  • Class II HLA Binding Assay

    Cell-free in vitro assay that measures relative binding affinity of putative HLA ligands using recombinant Class II HLA-DR supertype alleles.

    Assays & in vitro testing

  • Generic Peptide PANDA® Assays

    Assays for assessing immunogenic potential of generic peptide APIs and associated impurities.

    Assays & in vitro testing

  • Trusted Expert Advice (TEA)

    Consulting service providing expert immunogenicity advice across development programs.

  • IRA / ISI Regulatory Writing Support

    Regulatory writing support for immunogenicity risk assessment and integrated summaries.

Capabilities

Assays and studies
Immunogenicity · Peptides · Antibodies · Cell-free expression · ADCs · Cell-free in vitro assay · Competition-based assay · HLA binding assay · In vitro validation assay · Immunogenicity assessment · T cell epitope mapping · Epitope density analysis
Scale and capacity
13M+ sequences analyzed
Therapeutic areas
Immunogenicity assessment · Therapeutic development · Vaccine design · Regulatory strategy · Biologics · Antibody-drug conjugates · Infectious disease · Cancer

Instruments and platforms

  • BLAST

Modalities and species

Modalities
Small molecule · Antibody · ADC · Peptide · Vaccine
Species and models
Humans · Livestock

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

Company

Type
CRO
Ownership
Woman-owned, as registered with SAM.gov or stated on their site

Locations

Address
188 Valley Street, Suite 424 Providence, RI 02909, USA
Sites
Providence, USA
Serves
USA

Similar labs

Work here? Claim this listing